Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ASP Isotopes Inc. (ASPI)

ASP Isotopes says Renergen's Virginia Gas Project has stable liquid helium output

Positive Impact 3 of 5 other Written later

ASP Isotopes disclosed that Tetra4, a subsidiary of Renergen Limited, has completed commissioning and achieved stable liquid helium production at the Virginia Gas Project in South Africa. The filing reports no revenue or financial results, and the company said it is ramping toward nameplate capacity, which it expects to reach during the fourth quarter of 2026. For shareholders, this is an operational step toward initial deliveries, but the filing does not quantify its financial effect.

Key points

  • Tetra4 completed commissioning and achieved stable liquid helium production, announced October 26, 2026.
  • Liquid helium is accumulating in cryogenic storage ahead of initial deliveries under existing offtake agreements.
  • The company expects Renergen's nameplate capacity to be reached during the fourth quarter of 2026.
  • Phase 1 is expected to produce approximately 70 Mcf/day of liquid helium and approximately 2,500 GJ/day of LNG.

The filing

CompanyASP Isotopes Inc. (ASPI)
Form8-K, current report
Filed with the SECOct 26, 2026, 8:15 AM ET
Accession number0001193125-26-431084

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.